Cargando…

Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods

Macaques play a central role in the development of human tuberculosis (TB) vaccines. Immune and challenge responses differ across macaque and human subpopulations. We used novel immunostimulation/immunodynamic modeling methods in a proof-of-concept study to determine which macaque subpopulations bes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rhodes, Sophie J., Sarfas, Charlotte, Knight, Gwenan M., White, Andrew, Pathan, Ansar A., McShane, Helen, Evans, Thomas G., Fletcher, Helen, Sharpe, Sally, White, Richard G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2017
Materias:	Vaccines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339646/ https://www.ncbi.nlm.nih.gov/pubmed/28077441 http://dx.doi.org/10.1128/CVI.00525-16

Ejemplares similares

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

Dose finding for new vaccines: The role for immunostimulation/immunodynamic modelling
por: Rhodes, Sophie J., et al.
Publicado: (2019)

Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making
por: Rhodes, Sophie J., et al.
Publicado: (2018)

Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling
por: Rhodes, Sophie, et al.
Publicado: (2022)

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
por: Loxton, André G., et al.
Publicado: (2017)

Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques
por: Sarfas, Charlotte, et al.
Publicado: (2021)

Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
por: Ahmad, Shaheer, et al.
Publicado: (2019)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
por: Harris, Stephanie A., et al.
Publicado: (2014)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Safety of BCG vaccination and revaccination in healthcare workers
por: Villanueva, Paola, et al.
Publicado: (2023)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1
por: Fletcher, Helen A., et al.
Publicado: (2008)

Differences in host immune populations between rhesus macaques and cynomolgus macaque subspecies in relation to susceptibility to Mycobacterium tuberculosis infection
por: Sibley, Laura, et al.
Publicado: (2021)

TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination
por: White, Andrew D., et al.
Publicado: (2021)

From immune equilibrium to immunodynamics
por: Chen, Xiaoping
Publicado: (2022)

Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2020)

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
por: Pathan, Ansar A., et al.
Publicado: (2007)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
por: Pathan, Ansar A., et al.
Publicado: (2012)

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
por: Pathan, Ansar A., et al.
Publicado: (2011)

Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2022)

Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana
por: Yamoah, Peter, et al.
Publicado: (2023)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
por: Harris, Stephanie A., et al.
Publicado: (2018)

Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains
por: da Silva, Andreon Santos Machado, et al.
Publicado: (2021)

Human Properdin Modulates Macrophage: Mycobacterium bovis BCG Interaction via Thrombospondin Repeats 4 and 5
por: Al-Mozaini, Maha Ahmed, et al.
Publicado: (2018)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge
por: Morrison, Alexandra L., et al.
Publicado: (2023)

Immunodynamics of explanted human tumors for immuno‐oncology
por: Dubuisson, Agathe, et al.
Publicado: (2020)

Editorial Commentary: Understanding BCG Is the Key to Improving It
por: McShane, Helen
Publicado: (2014)

A Nonhuman Primate Scrub Typhus Model: Protective Immune Responses Induced by pKarp47 DNA Vaccination in Cynomolgus Macaques
por: Paris, Daniel H., et al.
Publicado: (2015)

Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites
por: Hofmeyer, Kimberly A., et al.
Publicado: (2016)

Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
por: Tabeling, Christoph, et al.
Publicado: (2022)

Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus
por: Urakami, Akane, et al.
Publicado: (2017)

Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006)

Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022)

Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2(+) T cells compared with the aminobisphosphonate drug zoledronic acid
por: Fenn, J, et al.
Publicado: (2022)

High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation
por: Sibley, Laura, et al.
Publicado: (2021)

Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques following SARS-CoV-2 Vaccination and Infection
por: Jacob-Dolan, Catherine, et al.
Publicado: (2021)

Complete Genome Sequence of Mycobacterium bovis BCG SL222 Sofia, the First WHO Reference Reagent for the M. bovis BCG Vaccine of the Russian BCG-I Substrain
por: Panaiotov, Stefan, et al.
Publicado: (2021)

Reverse immunodynamics: a new method for identifying targets of protective immunity
por: Spensley, Katrina J., et al.
Publicado: (2019)

Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques
por: Dagotto, Gabriel, et al.
Publicado: (2021)

Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur
por: Berrêdo-Pinho, Marcia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_20j1ku7mfsq32tjj7ri09jo52t